RxDoctor Payments Data

Rachelle Jaramillo, PA

Medical · Glenns Ferry, IDNPI 1962654673

Payments from drug & device makers

$646in general payments, 2019–2025

Across 33 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$345
  • Novo Nordisk$132
  • Pfizer$72
  • Genentech USA, Inc.$55
  • Biohaven Pharmaceutical Holding Company Ltd.$14
  • Boston Scientific$14
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$646100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$646 in reported general payments places this provider in the 60th percentile of 265 medical providers in Idaho.

See all medical providers in Idaho

Medicare billing

Part B allowed, 2024
$28,027
Medicare patients
123
Services billed
525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole13$26,648
VraylarCariprazine Hcl20$26,571
RybelsusSemaglutide30$26,239
OzempicSemaglutide22$21,041
XareltoRivaroxaban22$14,921
JanuviaSitagliptin Phosphate17$13,272
LinzessLinaclotide15$13,032
TrulicityDulaglutide13$12,554
FarxigaDapagliflozin Propanediol12$10,104
Incruse ElliptaUmeclidinium Bromide15$5,001
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$3,620
Lacosamide22$2,666
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,463
Venlafaxine Hcl ErVenlafaxine Hcl16$2,423
Aripiprazole21$2,191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$132$47,28052 claims
AbbVieVraylar, Linzess$345$39,60335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 265 medical providers in Idaho.

Other medical in Glenns Ferry

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →